1. Home
  2. MEOH vs HRMY Comparison

MEOH vs HRMY Comparison

Compare MEOH & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEOH
  • HRMY
  • Stock Information
  • Founded
  • MEOH 1968
  • HRMY 2017
  • Country
  • MEOH Canada
  • HRMY United States
  • Employees
  • MEOH N/A
  • HRMY N/A
  • Industry
  • MEOH Major Chemicals
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • MEOH Industrials
  • HRMY Health Care
  • Exchange
  • MEOH Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • MEOH 2.2B
  • HRMY 2.0B
  • IPO Year
  • MEOH N/A
  • HRMY 2020
  • Fundamental
  • Price
  • MEOH $33.60
  • HRMY $32.10
  • Analyst Decision
  • MEOH Buy
  • HRMY Strong Buy
  • Analyst Count
  • MEOH 9
  • HRMY 9
  • Target Price
  • MEOH $46.89
  • HRMY $54.22
  • AVG Volume (30 Days)
  • MEOH 731.0K
  • HRMY 661.5K
  • Earning Date
  • MEOH 07-29-2025
  • HRMY 08-05-2025
  • Dividend Yield
  • MEOH 2.18%
  • HRMY N/A
  • EPS Growth
  • MEOH 24.27
  • HRMY 13.13
  • EPS
  • MEOH 3.06
  • HRMY 2.62
  • Revenue
  • MEOH $3,700,592,000.00
  • HRMY $744,852,000.00
  • Revenue This Year
  • MEOH $10.01
  • HRMY $20.10
  • Revenue Next Year
  • MEOH $14.10
  • HRMY $18.01
  • P/E Ratio
  • MEOH $11.08
  • HRMY $12.20
  • Revenue Growth
  • MEOH 2.77
  • HRMY 20.62
  • 52 Week Low
  • MEOH $25.46
  • HRMY $26.47
  • 52 Week High
  • MEOH $54.49
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • MEOH 47.30
  • HRMY 42.59
  • Support Level
  • MEOH $32.66
  • HRMY $31.25
  • Resistance Level
  • MEOH $34.33
  • HRMY $33.69
  • Average True Range (ATR)
  • MEOH 1.38
  • HRMY 1.01
  • MACD
  • MEOH -0.28
  • HRMY -0.16
  • Stochastic Oscillator
  • MEOH 18.37
  • HRMY 20.66

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: